Shares of Moderna dropped 9% to $125.85 at 15:51 EST on Tuesday, after two sequential sessions in a row of losses. The Nasdaq Stock Market is rising 0.39% to $12,792.10, after two successive sessions in a row of losses. This seems, as yet, a somewhat positive trend trading session today.
Moderna's last close was $138.30, 41.84% below its 52-week high of $178.50.
Moderna's Sales
Moderna's sales growth is 1841.7% for the current quarter and 19117.5% for the next. The company's growth estimates for the current quarter is a negative 2.7% and positive 660% for the next.
Moderna's Revenue
Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.
Moderna's Stock Yearly Top and Bottom Value
Moderna's stock is valued at $125.85 at 15:51 EST, way below its 52-week high of $178.50 and way above its 52-week low of $17.68.
Moderna's Moving Average
Moderna's value is above its 50-day moving average of $116.47 and way higher than its 200-day moving average of $80.87.Previous days news about Moderna
Moderna shot cleared in U.S., boosting immunization effort. According to Bloomberg Quint on Sat Dec 19, "Moderna Inc.'s Covid-19 vaccine was cleared by U.S. regulators, the second vaccine to gain emergency authorization this month as a historic mass immunization effort ramps up across the country.", "For Moderna, whose stock-market ticker symbol is MRNA, it is also the first product from the company to be cleared by regulators for use."
Moderna, Exxon, Alphabet, Amazon: stocks that defined the week. According to The Wall Street Journal on Sat Dec 19, "Moderna shares rose 5.1% Thursday when an advisory panel cleared the way for Friday night's authorization.", "Moderna, a ten-year-old biotech that has never had a product cleared by the FDA, expects to deliver a total of 20 million doses by the end of December. "
Statement on the U.S. authorization of the Moderna Covid-19 vaccine. According to Business Insider on Sat Dec 19, "Health Canada has been reviewing Moderna's vaccine since it was submitted on October 12, 2020, and is expediting the review of COVID-19 vaccines. ", "There is still information and data to be provided by Moderna for review. "
Moderna to begin delivery; London lockdown ordered: virus update. According to Bloomberg Quint on Sat Dec 19, "The advisers cast the vote in an emergency meeting Saturday after the Food and Drug Administration authorized use of Moderna's shot Friday.", "The MHRA also "already started a rolling review to assess" Moderna's Covid-19 vaccine "to make sure it meets strict standards on safety, quality and effectiveness," said Nadhim Zahawi, minister for Covid Vaccine Deployment, on Twitter. "
Philippines to start vaccine talks with Moderna by year-end: CNN. According to Bloomberg Quint on Mon Dec 21, "The Philippines will start talks with Moderna Inc. on or before Dec. 30 to secure supply of the company's coronavirus vaccine, Foreign Affairs Secretary Teodoro Locsin said Monday.", ""Moderna is interested in giving an allocation," he said in a live-streamed interview with CNN Philippines, citing Philippine ambassador to the U.S. Jose Manuel Romualdez."